This key mechanism by which hepatocyte’s Zbtb18 expression alleviates NAFLD and consequent liver fibrosis was further verified by FXR’s deletion and forced expression in mice and cultured mouse primary hepatocytes (MPHs). The gene discussed is ZBTB18; the disease is metabolic dysfunction-associated steatotic liver disease.